
DIACEUTICS PLC
Aktie · GB00BJQTGV64 · A2PF80 (XLON)
1,29 GBP
Schlusskurs XLON 09.06.2025:
128,70 GBX
London (XLON) · Aktuelle Kurse und Charts bei MoneyPeak
09.06.2025 14:45
Aktuelle Kurse von DIACEUTICS PLC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
---|---|---|---|---|---|
![]() London |
DXRX.L
|
GBX
|
09.06.2025 14:45
|
128,70 GBX
| 130,00 GBX
-1,00 %
|
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 1,74 % | 7,25 % | -5,60 % | 9,07 % | 0,55 % | -14,20 % |
Firmenprofil zu DIACEUTICS PLC Aktie
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Unternehmensdaten
Name DIACEUTICS PLC
Firma Diaceutics PLC
Website
https://www.diaceutics.com
Heimatbörse
London

WKN A2PF80
ISIN GB00BJQTGV64
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Mr. Ryan Keeling
Marktkapitalisierung 102 Mio
Land Großbritannien und Nordirland
Währung GBP
Mitarbeiter 0,2 T
Adresse Building Two, BT9 6GW Belfast
IPO Datum 2019-03-21
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 7DC.F |
London | DXRX.L |
Weitere Aktien
Investoren die DIACEUTICS PLC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.